title: Reversible posterior leukoencephalopathy syndrome after rituximab.
authors.affiliation: Department of Emergency Medicine, Stony Brook University, Stony Brook, NY 11794-8191, USA.
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Zito
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Lee
authors.forename: Scott
authors.initials: S
authors.lastname: Johnson
authors.forename: Adam
authors.initials: A
authors.lastname: Singer
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Vacirca
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D001921:Brain / Q000000981:diagnostic imaging; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging; D000069283:Rituximab; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab